135 related articles for article (PubMed ID: 12356750)
1. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Hurbin A; Dubrez L; Coll JL; Favrot MC
J Biol Chem; 2002 Dec; 277(51):49127-33. PubMed ID: 12356750
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Hurbin A; Dubrez L; Coll JL; Favrot MC
Ann N Y Acad Sci; 2003 Dec; 1010():354-7. PubMed ID: 15033751
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.
Hurbin A; Coll JL; Dubrez-Daloz L; Mari B; Auberger P; Brambilla C; Favrot MC
J Biol Chem; 2005 May; 280(20):19757-67. PubMed ID: 15767261
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
Busser B; Sancey L; Josserand V; Niang C; Favrot MC; Coll JL; Hurbin A
Mol Ther; 2010 Mar; 18(3):528-35. PubMed ID: 19826406
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.
Busser B; Sancey L; Josserand V; Niang C; Khochbin S; Favrot MC; Coll JL; Hurbin A
Mol Ther; 2010 Mar; 18(3):536-43. PubMed ID: 19826407
[TBL] [Abstract][Full Text] [Related]
7. Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.
Yonesaka K; Zejnullahu K; Lindeman N; Homes AJ; Jackman DM; Zhao F; Rogers AM; Johnson BE; Jänne PA
Clin Cancer Res; 2008 Nov; 14(21):6963-73. PubMed ID: 18980991
[TBL] [Abstract][Full Text] [Related]
8. Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated ras-stimulated intestinal epithelial cells.
Zushi S; Shinomura Y; Kiyohara T; Miyazaki Y; Tsutsui S; Sugimachi M; Higashimoto Y; Kanayama S; Matsuzawa Y
Int J Cancer; 1997 Dec; 73(6):917-23. PubMed ID: 9399676
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib (Iressa, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells.
Kishida O; Miyazaki Y; Murayama Y; Ogasa M; Miyazaki T; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Shimomura I; Shinomura Y
Cancer Chemother Pharmacol; 2005 Jun; 55(6):584-94. PubMed ID: 15723219
[TBL] [Abstract][Full Text] [Related]
11. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
Ogunwobi OO; Beales IL
Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
[TBL] [Abstract][Full Text] [Related]
12. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
[TBL] [Abstract][Full Text] [Related]
13. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
14. Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer.
Vollebergh MA; Kappers I; Klomp HM; Buning-Kager JC; Korse CM; Hauptmann M; de Visser KE; van den Heuvel MM; Linn SC
J Thorac Oncol; 2010 Dec; 5(12):1939-48. PubMed ID: 21102259
[TBL] [Abstract][Full Text] [Related]
15. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Hayama S; Murakami H; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Cancer Res; 2005 Oct; 65(20):9176-84. PubMed ID: 16230376
[TBL] [Abstract][Full Text] [Related]
16. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib ("Iressa", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells.
Kishida O; Miyazaki Y; Murayama Y; Ogasa M; Miyazaki T; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Shimomura I; Shinomura Y
Cancer Chemother Pharmacol; 2005 Apr; 55(4):393-403. PubMed ID: 15723263
[TBL] [Abstract][Full Text] [Related]
18. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin.
Lemjabbar H; Li D; Gallup M; Sidhu S; Drori E; Basbaum C
J Biol Chem; 2003 Jul; 278(28):26202-7. PubMed ID: 12711607
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
20. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292.
Chokki M; Mitsuhashi H; Kamimura T
Life Sci; 2006 May; 78(26):3051-7. PubMed ID: 16427093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]